Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0242706 (
hyperoxia
)
5,219
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The pathogenesis of
hyperoxia
lung injury and the mechanism of amygdalin on type 2 alveolar epithelial cells (AEC2) isolated from premature rat lungs in vitro were investigated. AEC2 were obtained by primary culture from 20-days fetal rat lung and
hyperoxia
-exposed cell model was established. Cell proliferating viability was examined by MTT assay after treatment of amygdalin at various concentrations. DNA content and the proliferating cell nuclear antigen (PCNA) protein expression of AEC2 were measured by using flow cytometry and immunocytochemistry respectively after 24 h of
hyperoxia
exposure or amygdalin treatment. The results showed that
hyperoxia
inhibited the proliferation and decreased PCNA protein expression in A-EC2 of premature rat in vitro.
Amygdalin
at the concentration range of 50-200 micromol/L stimulated the proliferation of AEC2 in a dose-dependent manner, however, 400 micromol/L amygdalin inhibited the proliferation of AEC2.
Amygdalin
at the concentration of 200 micromol/L played its best role in facilitating proliferation of AEC2s in vitro and could partially ameliorated the changes of proliferation in
hyperoxia
exposed AEC2 of premature rat. It has been suggested that
hyperoxia
inhibited the proliferation of AEC2s of premature rat, which may contribute to
hyperoxia
lung injury.
Amygdalin
may play partial protective role in
hyperoxia
-induced lung injury.
...
PMID:Effect of amygdalin on the proliferation of hyperoxia-exposed type II alveolar epithelial cells isolated from premature rat. 1531 31